Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
SAB Biotherapeutics (SABS) just unveiled an update.
The Company has announced the appointment of Mr. Conley through a press release on May 30, 2024. This information, while provided to the public, is not intended for legal liability under the Securities Exchange Act of 1934, nor is it to be included in any future securities filings unless explicitly stated.
For a thorough assessment of SABS stock, go to TipRanks’ Stock Analysis page.